Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study ; volume:21 ; number:1 ; day:28 ; month:5 ; year:2019 ; pages:1-8 ; date:12.2019
Arthritis Research & Therapy ; 21, Heft 1 (28.5.2019), 1-8, 12.2019
- Creator
-
Jaworski, Janusz
Matucci-Cerinic, Marco
Schulze-Koops, Hendrik
Buch, Maya H.
Kucharz, Eugeniusz J.
Allanore, Yannick
Kavanaugh, Arthur
Young, Philip
Babic, Goran
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-019-1907-x
- URN
-
urn:nbn:de:101:1-2019112406310431793311
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jaworski, Janusz
- Matucci-Cerinic, Marco
- Schulze-Koops, Hendrik
- Buch, Maya H.
- Kucharz, Eugeniusz J.
- Allanore, Yannick
- Kavanaugh, Arthur
- Young, Philip
- Babic, Goran
- SpringerLink (Online service)
Other Objects (12)
Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
Correction to: GP2015: An Etanercept Biosimilar
Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review
Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Afebriles Erysipel unter Etanercept-Therapie
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious
Etanercept - therapeutische Anwendungen in Klinik und Praxis
Perispinal etanercept: Potential as an Alzheimer therapeutic
Etanercept and venous thromboembolism: a case series
Etanercept-Induced Anti-Glomerular Basement Membrane Disease
Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
Correction to: GP2015: An Etanercept Biosimilar
Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review
Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Afebriles Erysipel unter Etanercept-Therapie
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious
Etanercept - therapeutische Anwendungen in Klinik und Praxis
Perispinal etanercept: Potential as an Alzheimer therapeutic
Etanercept and venous thromboembolism: a case series
Etanercept-Induced Anti-Glomerular Basement Membrane Disease
Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
Correction to: GP2015: An Etanercept Biosimilar
Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review
Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Erratum to: Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali®) Versus Etanercept (Enbrel®) - Findings from a Nurse Survey in Europe
Afebriles Erysipel unter Etanercept-Therapie
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious
Etanercept - therapeutische Anwendungen in Klinik und Praxis
Perispinal etanercept: Potential as an Alzheimer therapeutic
Etanercept and venous thromboembolism: a case series